Dalfarex (Fampridine) is a potassium channel blocker produced by Alhavi Pharmaceutical.
It improves nerve signal conduction in patients with Multiple Sclerosis (MS), helping to increase walking speed and mobility.
This medication is prescribed for patients with walking difficulties resulting from MS.
Use of Dalfarex should be under medical supervision, with regular monitoring of possible side effects.
Dalfarex (Fampridine)
Dosage form: Tablet
Dalfarex is indicated for:
• Improvement of walking ability in patients with Multiple Sclerosis (MS)
Fampridine works by blocking potassium channels and enhancing nerve signal transmission, leading to better muscle control and mobility.
Treatment should always be supervised by a healthcare professional to monitor response and side effects.
• Standard dose: 10 mg every 12 hours
• Can be taken with or without food
• Do not exceed the recommended dose
• Tablets should be swallowed whole and not crushed or chewed
• Always follow your physician’s instructions and report any side effects promptly